Concepts (187)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cellulose | 4 | 2025 | 27 | 1.910 |
Why?
|
| Theca Cells | 5 | 2012 | 18 | 1.510 |
Why?
|
| Estrogen Receptor alpha | 2 | 2025 | 439 | 1.210 |
Why?
|
| Industrial Waste | 2 | 2025 | 3 | 1.190 |
Why?
|
| Waste Management | 2 | 2025 | 3 | 1.190 |
Why?
|
| Chorionic Gonadotropin | 3 | 2012 | 81 | 0.990 |
Why?
|
| Anacardium | 1 | 2025 | 3 | 0.950 |
Why?
|
| Biomass | 1 | 2024 | 23 | 0.880 |
Why?
|
| Plant Leaves | 1 | 2024 | 55 | 0.860 |
Why?
|
| Small Molecule Libraries | 6 | 2024 | 135 | 0.860 |
Why?
|
| DNA | 8 | 2024 | 1483 | 0.670 |
Why?
|
| Mammary Glands, Animal | 2 | 2019 | 452 | 0.610 |
Why?
|
| Cell Cycle Proteins | 2 | 2012 | 686 | 0.540 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 3 | 2025 | 38 | 0.510 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2018 | 239 | 0.510 |
Why?
|
| Tamoxifen | 1 | 2018 | 354 | 0.500 |
Why?
|
| Insulin | 2 | 2012 | 1167 | 0.490 |
Why?
|
| Multiprotein Complexes | 2 | 2012 | 201 | 0.450 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2018 | 634 | 0.450 |
Why?
|
| Signal Transduction | 4 | 2023 | 4725 | 0.430 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 773 | 0.410 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2012 | 446 | 0.400 |
Why?
|
| Androgens | 2 | 2012 | 277 | 0.390 |
Why?
|
| Polyesters | 2 | 2024 | 41 | 0.390 |
Why?
|
| Luteinizing Hormone | 1 | 2012 | 136 | 0.370 |
Why?
|
| beta-Lactamase Inhibitors | 2 | 2023 | 60 | 0.360 |
Why?
|
| Transcriptome | 1 | 2018 | 1123 | 0.350 |
Why?
|
| Breast Neoplasms | 2 | 2025 | 2682 | 0.330 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 2064 | 0.320 |
Why?
|
| Tensile Strength | 3 | 2025 | 45 | 0.320 |
Why?
|
| Cyclic AMP | 1 | 2010 | 234 | 0.320 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2024 | 608 | 0.310 |
Why?
|
| Proteins | 3 | 2019 | 1038 | 0.310 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2009 | 31 | 0.300 |
Why?
|
| Escherichia coli | 3 | 2024 | 995 | 0.300 |
Why?
|
| beta-Lactamases | 4 | 2024 | 208 | 0.300 |
Why?
|
| Hydrolysis | 2 | 2025 | 159 | 0.280 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2010 | 503 | 0.270 |
Why?
|
| Ligands | 2 | 2025 | 495 | 0.250 |
Why?
|
| Sirolimus | 3 | 2012 | 241 | 0.240 |
Why?
|
| Rats | 5 | 2012 | 3612 | 0.240 |
Why?
|
| Waste Products | 1 | 2025 | 5 | 0.240 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2012 | 1225 | 0.240 |
Why?
|
| X-Ray Diffraction | 1 | 2025 | 105 | 0.230 |
Why?
|
| Phosphoproteins | 3 | 2012 | 443 | 0.230 |
Why?
|
| Agriculture | 1 | 2025 | 32 | 0.230 |
Why?
|
| Particle Size | 1 | 2025 | 149 | 0.230 |
Why?
|
| Cells, Cultured | 4 | 2018 | 3061 | 0.220 |
Why?
|
| Sansevieria | 1 | 2024 | 1 | 0.220 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2024 | 136 | 0.210 |
Why?
|
| Protein Domains | 1 | 2025 | 260 | 0.210 |
Why?
|
| Contraceptive Agents, Male | 1 | 2024 | 35 | 0.210 |
Why?
|
| Phosphorylation | 3 | 2012 | 1613 | 0.210 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2012 | 579 | 0.210 |
Why?
|
| Contraception | 1 | 2024 | 61 | 0.210 |
Why?
|
| Biofilms | 1 | 2024 | 99 | 0.210 |
Why?
|
| Animals | 12 | 2024 | 34951 | 0.200 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2023 | 57 | 0.200 |
Why?
|
| Copper | 1 | 2023 | 75 | 0.200 |
Why?
|
| Estradiol | 1 | 2025 | 488 | 0.190 |
Why?
|
| Ribosomal Protein S6 | 2 | 2012 | 14 | 0.180 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2012 | 21 | 0.180 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 2 | 2012 | 167 | 0.180 |
Why?
|
| Anti-Bacterial Agents | 2 | 2023 | 2553 | 0.180 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 2 | 2012 | 11 | 0.170 |
Why?
|
| Corchorus | 1 | 2020 | 2 | 0.170 |
Why?
|
| Androstenedione | 2 | 2012 | 15 | 0.170 |
Why?
|
| Egg Shell | 1 | 2020 | 4 | 0.170 |
Why?
|
| Composite Resins | 1 | 2020 | 8 | 0.170 |
Why?
|
| Glass | 1 | 2020 | 11 | 0.170 |
Why?
|
| Protein Binding | 1 | 2025 | 1735 | 0.170 |
Why?
|
| Gene Silencing | 2 | 2012 | 240 | 0.170 |
Why?
|
| Transcription Factors | 1 | 2010 | 2494 | 0.170 |
Why?
|
| Nanostructures | 1 | 2020 | 65 | 0.160 |
Why?
|
| Cell Proliferation | 3 | 2012 | 2512 | 0.160 |
Why?
|
| Female | 11 | 2025 | 70664 | 0.160 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2012 | 343 | 0.160 |
Why?
|
| Hydrocarbons, Halogenated | 1 | 2019 | 5 | 0.160 |
Why?
|
| Tilapia | 1 | 1999 | 1 | 0.160 |
Why?
|
| RNA, Small Interfering | 2 | 2012 | 691 | 0.150 |
Why?
|
| Nitro Compounds | 1 | 2019 | 18 | 0.150 |
Why?
|
| Amines | 1 | 2019 | 37 | 0.150 |
Why?
|
| Boron Compounds | 1 | 2019 | 34 | 0.150 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2019 | 236 | 0.150 |
Why?
|
| Ovarian Neoplasms | 1 | 2023 | 463 | 0.150 |
Why?
|
| Water Pollutants, Chemical | 1 | 1999 | 41 | 0.150 |
Why?
|
| Urea | 1 | 1999 | 227 | 0.150 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2018 | 20 | 0.140 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2018 | 210 | 0.130 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2019 | 541 | 0.130 |
Why?
|
| Binding Sites | 1 | 2019 | 1256 | 0.130 |
Why?
|
| Mice, Nude | 1 | 2018 | 757 | 0.130 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 265 | 0.130 |
Why?
|
| Carrier Proteins | 2 | 2012 | 1050 | 0.120 |
Why?
|
| Peptides | 1 | 2020 | 846 | 0.120 |
Why?
|
| Ribosomal Protein S6 Kinases | 2 | 2012 | 50 | 0.120 |
Why?
|
| Mice, Inbred BALB C | 1 | 2018 | 1051 | 0.120 |
Why?
|
| Catalysis | 3 | 2020 | 139 | 0.110 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2018 | 998 | 0.110 |
Why?
|
| Receptors, Estrogen | 1 | 2018 | 741 | 0.110 |
Why?
|
| Bacterial Proteins | 1 | 2020 | 930 | 0.110 |
Why?
|
| Mutation | 2 | 2025 | 6248 | 0.110 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 945 | 0.110 |
Why?
|
| Cholesterol Side-Chain Cleavage Enzyme | 1 | 2012 | 4 | 0.100 |
Why?
|
| Catalytic Domain | 2 | 2024 | 180 | 0.100 |
Why?
|
| Enzyme Activation | 2 | 2012 | 618 | 0.100 |
Why?
|
| Colforsin | 1 | 2012 | 51 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2012 | 92 | 0.100 |
Why?
|
| Enzyme Induction | 1 | 2012 | 97 | 0.100 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2012 | 53 | 0.100 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 1879 | 0.090 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2012 | 98 | 0.090 |
Why?
|
| Cholesterol | 2 | 2009 | 559 | 0.090 |
Why?
|
| Mice | 4 | 2024 | 18565 | 0.090 |
Why?
|
| Genome-Wide Association Study | 1 | 2019 | 1830 | 0.090 |
Why?
|
| Cattle | 1 | 2012 | 571 | 0.090 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2012 | 175 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 399 | 0.090 |
Why?
|
| Genomics | 1 | 2019 | 1651 | 0.090 |
Why?
|
| Gene Expression Regulation | 2 | 2010 | 2444 | 0.090 |
Why?
|
| Gene Library | 2 | 2023 | 212 | 0.090 |
Why?
|
| Cyclin D3 | 1 | 2010 | 11 | 0.080 |
Why?
|
| RNA Interference | 1 | 2012 | 516 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 365 | 0.080 |
Why?
|
| Metformin | 1 | 2012 | 165 | 0.080 |
Why?
|
| Cyclin D1 | 1 | 2010 | 113 | 0.080 |
Why?
|
| Aminoglutethimide | 1 | 2009 | 2 | 0.080 |
Why?
|
| Ovary | 1 | 2012 | 371 | 0.080 |
Why?
|
| Hydroxycholesterols | 1 | 2009 | 4 | 0.080 |
Why?
|
| Humans | 8 | 2025 | 132083 | 0.080 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2009 | 33 | 0.080 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 79 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2009 | 109 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2010 | 493 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2009 | 1008 | 0.070 |
Why?
|
| Cocos | 1 | 2025 | 3 | 0.060 |
Why?
|
| Saccharum | 1 | 2025 | 12 | 0.060 |
Why?
|
| Oryza | 1 | 2025 | 29 | 0.060 |
Why?
|
| Blood-Testis Barrier | 1 | 2024 | 13 | 0.060 |
Why?
|
| Receptors, Eph Family | 1 | 2024 | 22 | 0.050 |
Why?
|
| Receptor, EphA2 | 1 | 2024 | 29 | 0.050 |
Why?
|
| Flowers | 1 | 2024 | 10 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2010 | 2679 | 0.050 |
Why?
|
| beta-Lactams | 1 | 2023 | 56 | 0.050 |
Why?
|
| Sphingomyelins | 1 | 2023 | 15 | 0.050 |
Why?
|
| Alloys | 1 | 2023 | 15 | 0.050 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2023 | 15 | 0.050 |
Why?
|
| Electrodes | 1 | 2023 | 91 | 0.050 |
Why?
|
| Penicillins | 1 | 2023 | 155 | 0.050 |
Why?
|
| Water | 1 | 2024 | 196 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2024 | 590 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2024 | 408 | 0.050 |
Why?
|
| Time Factors | 1 | 2012 | 6445 | 0.050 |
Why?
|
| Semen | 1 | 2022 | 81 | 0.050 |
Why?
|
| Testis | 1 | 2024 | 423 | 0.050 |
Why?
|
| Chromatography, Liquid | 1 | 2022 | 239 | 0.040 |
Why?
|
| Endometriosis | 1 | 2024 | 174 | 0.040 |
Why?
|
| Drug Discovery | 1 | 2022 | 174 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2009 | 1596 | 0.040 |
Why?
|
| Methacrylates | 1 | 2020 | 18 | 0.040 |
Why?
|
| Powders | 1 | 2020 | 24 | 0.040 |
Why?
|
| Filtration | 1 | 2020 | 23 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2023 | 827 | 0.040 |
Why?
|
| Surface Properties | 1 | 2020 | 95 | 0.040 |
Why?
|
| Elasticity | 1 | 2020 | 93 | 0.040 |
Why?
|
| Materials Testing | 1 | 2020 | 78 | 0.040 |
Why?
|
| Nanotechnology | 1 | 2020 | 50 | 0.040 |
Why?
|
| Cell Movement | 1 | 2024 | 891 | 0.040 |
Why?
|
| Buffers | 1 | 2020 | 32 | 0.040 |
Why?
|
| Cyclization | 1 | 2020 | 17 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2022 | 288 | 0.040 |
Why?
|
| Gills | 1 | 1999 | 6 | 0.040 |
Why?
|
| Palladium | 1 | 2019 | 15 | 0.040 |
Why?
|
| Fresh Water | 1 | 1999 | 21 | 0.040 |
Why?
|
| Oxygen | 1 | 2023 | 571 | 0.040 |
Why?
|
| Carbohydrates | 1 | 1999 | 39 | 0.040 |
Why?
|
| Carbohydrate Metabolism | 1 | 1999 | 51 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2023 | 1494 | 0.040 |
Why?
|
| India | 1 | 1999 | 237 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2019 | 323 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 1999 | 1038 | 0.020 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2012 | 60 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2012 | 153 | 0.020 |
Why?
|
| Liver | 1 | 1999 | 1801 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 309 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2012 | 482 | 0.020 |
Why?
|
| Male | 2 | 2024 | 64904 | 0.020 |
Why?
|